Abstract Sarcomagenesis, in contrast to carcinogenesis, is poorly understood. Microsatellite instability has been implicated in the development of many cancers, in particular those associated with chronic inflammatory conditions. In an experimental animal model, rats developed not only a peri-implantational chronic inflammatory reaction, but also malignant mesenchymal tumors in response to different biomaterials. Therefore, it was the aim of our study to test if the development of biomaterial-induced sarcomas is characterized by a mutator phenotype. A multiplex-PCR approach was designed to screen biomaterial-induced sarcomas for the presence of microsatellite instability. Seven different microsatellite loci were tested in ten tumors for microsatellite instability using a fluorochrome-labelled multiplex-PCR and subsequent fragment analysis. All tumors provided a microsatellite-stable phenotype at all loci tested. Our data suggest that microsatellite instability is rarely or not at all a feature of malignant transformation of biomaterialinduced soft tissue tumors. Thus, there is no evidence that a mutator phenotype is a hallmark of biomaterial-induced sarcomagenesis.
Introduction
Tumorigenesis is now widely accepted as resulting from a stepwise accumulation of genetic instability [1] . The biological and molecular mechanisms involved in the development of carcinomas in humans and mammals have been extensively investigated. In contrast, the molecular steps in the development of sarcomas and other soft tissue tumors are less well understood. A progression from a benign precursor lesion to malignant tumor, characterisitic of many epithelial tumors, is exceptional for soft tissue tumors. However, a biological continuum of benign and malignant soft tissue tumors has been postulated for example in the case of lipomatous [2] and nerve sheath tumors [3, 4] .
In a previous study, we had established an animal model for the tumorigenesis of soft tissue tumors [5] . Malignant mesenchymal tumors were induced around subcutaneously implanted biomaterial disks. In addition to fully developed tumors, implantation sites showed lymphocyte and macrophage infiltrates reflecting an inflammatory reaction, as a characteristic response to the implantation of foreign materials [6, 7] as well as hyper-proliferative lesions, reflecting precursor lesions. This animal model allowed a detailed investigation of sarcoma tumorigenesis, especially because a spectrum of preneoplastic lesions could be identified.
Several mechanisms are known to result in genetic instability and consequent malignant transformation of cells. One pathway is the development of chromosomal instability with numerical and structural chromosomal changes and aneuploidy of tumor cells. Another pathway is the development of a "mutator phenotype" with changes at the nucleotide level. These alterations may result in the accumulation of multiple mutations in genes relevant to cell growth and homeostasis, eventually leading to growth advantage and transformation of cells. Multiple short tandem repetitive DNA-sequences, also known as microsatellites, are present throughout the genome of humans and other mammals [8] . A mutator phenotype is frequently reflected by widespread sequence length alterations of these microsatellites, designated as microsatellite instability [9, 10] . Besides inherited deficiencies of mismatch repair (MMR) genes and inactivation by methylation, an underlying impairment of repair enzymes in association with chronic inflammation [11, 12] has been demonstrated, most likely due to oxidative stress [13] .
While there is a clear association of specific or typical chromosomal translocations or translocation of gene fusion products with many soft tissue tumors, microsatellite instability has also been reported for some entities [14] [15] [16] [17] . Since a chronic inflammatory condition is associated with microstallite-associated carcinogenesis, we sought to investigate if the tumorigenesis of biomaterial-induced sarcomas is based on the development of a mutator phenotype. Using the above-mentioned rat model, biomaterialinduced sarcomas were screened for microsatellite instability.
Materials and methods

Animal model
Ten formalin-fixed, paraffin-embedded tumor samples (Table 1) were retrieved from the previously published rat sarcoma collective [5] . Briefly, in this study a total of 490 Fischer rats had been implanted with nine different standard medical grade biomaterials. In about one quarter of implantations, animals developed (mostly malignant) mesenchymal tumors of different histological type, including fibrosarcomas, leimyosarcomas, and rhabdomyosarcomas, around the implantation sites.
Laser capture microdissection
Sections of normal and transformed tissues (either tumors or precursor lesions) from the above mentioned paraffin blocks were prepared on membrane mounted-slides (PALM MembraneSlides, P.A.L.M., Bernried, Germany) and de-paraffinized. Microdissection was performed using a PALM MicroBeam system with a pulsed UV-A nitrogen laser (337 nm). The selected areas were marked, cut out, and pulsed into a 0.5-ml microfuge tube with adhesive filling (PALM AdhesiveCaps, P.A.L.M.), taking care to keep the normal and tumor tissues separate. "Normal tissue" was prepared so distant from the implantation site that it was morphologically not affected by the implants and corresponding tissue reactions.
Multiplex PCR and fragment analysis
Since (in contrast to human and mouse) no well-established and characterized panels of markers for the analysis of microsatellite instability was described in rat, sequence information of rat microsatellite loci was taken from several studies [18] [19] [20] . In order to compensate for a potentially low sensitivity of these markers in detecting MSI, seven markers instead of the more common panel of five markers was used (Table 2 ). DNA was isolated by proteinase K digestion, followed by phenol-chloroform extraction and ethanol/salt precipitation using standard protocols [21] . Two multiplex PCR-reactions were performed using two different primer mixtures with fluorochrome-labelled oligonucleotide primers. In each case, either the forward or the reverse primer was fluorochrome-labelled. Primermix A contained oligonucleotide primers of the loci GH, NGFR, SECR, and UCP; primermix B contained oligonucleotide primers of the loci ANF, PPY, and SMST (Table 2) . Nonfluorescent oligonucleotide primers were purchased from biomers.net, Ulm, Germany and the fluorescent oligonucleotide primers from Sigma-Aldrich, Germany. The final 25-μl multiplex reaction mix consisted of the following: 12.5 μl Qiagen-Multiplex-Mastermix (Qiagen, Hilden, Germany), 2.5 μl 10× primer-mix, 7.5 μl H 2 O, and 2.5 μl template. The 10× primer-mix was composed by mixing 50 μM fluorescent primers and 100 μM nonfluorescent primers at a concentration of 2 μM each in H 2 O.
PCR was performed using a GeneAmp 9700 thermocycler (Applied Biosystems, Foster City, CA, USA) under the following conditions: initial denaturation at 95°for 15 min, followed by 45 cycles of: 30 s at 94°, 90 s at 54°, and 1 min at 72°with a final 30-min extension period at 60°. The resulting PCR-product was then analyzed by gel-electrophoresis on a 2% agarose gel and subsequent fragment analysis of the fluorescently labelled PCR products was performed using a Beckman Coulter CEQ 8000 Sequencer (Beckman Coulter, Krefeld, Germany) with the corresponding CEQ System software. The detected fragments of normal and malignant tissue were compared to determine the stability for each locus.
Results
Tissue selection and isolation of tumor and normal DNA Histology of the samples was re-evaluated in order to define suitable areas of tumor and non-neoplastic tissue, respectively. In all cases studied, a clear identification of tumors and non-tumorous areas was possible, providing the basis for the laser-capture analysis and tissue preparation (Fig. 1) . Following laser-capture (P.A.L.M.)-based tissue preparation and standard nucleic acid extraction, a sufficient amount and quality of DNA could be isolated from all samples analyzed.
Development of a multiplex-PCR assay for microsatellite instability testing PCR conditions were first optimized, and all samples were initially tested in a single PCR setting. In the case of the GH and PPY locus, respectively, significantly lower amplification sizes were observed when compared to information from either the gene bank (see Table 2 ) and/ or the literature [18] . In the case of the PPY locus, higher amplification sizes were observed. The SECR locus revealed rather a single peak instead of the characteristic stuttering pattern in all samples tested. However, all loci displayed a constant size comparing different animals (due to the same genetic background of animals).
After successfully testing each pair of oligonucleotide primers in a single-PCR, a multiplex-PCR-assay was designed by dividing the seven different primers into two groups of three or four primer pairs, respectively. Using this multiplex-PCR approach, all loci test were successfully amplified and analyzed by fluorescence-based fragment analysis. No difference between single PCR fragment analysis patterns and the multiplex approach was observed, Microsatellite loci and oligonucletide primer sequences information GH growth hormone, NGFR nerve growth factor receptor, SECR secretin, UCP uncoupling protein, SMST somatostatin, ANF atrial natriuretic factor, PPY pancreatic polypeptide a Sizes are indicated as expected according to NCBI database information and differed significantly from the fragment sizes observed in this study in case of the GH, UCP, and PPY loci, respectively indicating that the multiplex assay used was a valid method for the simultaneous testing of several microsatellite loci (Fig. 2) .
All microsatellite loci showed a stable phenotype A total of 140 microsatellites was analyzed, with 70 microsatellites displaying microsatellites of neoplastic or preneoplastic tissue, and the other 70 reflecting the corresponding normal tissue, respectively. Nearly all microsatellites were informative with the exception of three cases (PND locus of animals: one PMMA 86, two Si90, and four PVC 105). In these cases, the fragment analysis revealed signals which were too low or unspecific to be readable, so that a definite statement about the stability of the microsatellite loci for these particular samples could not be made.
For all other microsatellite loci tested, no size or frame shifts were observed on comparing normal and the tumor/ precursor lesion tissue (see examples in Fig. 3) . Thus, even assuming that the PND locus in case of the three tumors, in which this particular locus was not amplified, had shown a change in microstatellite pattern, the overall diagnostic criteria for microsatellite instability would not have been fulfilled. Therefore, all loci provided stable microsatellites. 
Discussion
The etiology of most benign and malignant soft tissue tumors is unknown. The vast majority of soft tissue tumors seem to arise without an apparent causative factor. Among suspected or proven causative factors are genetic and environmental factors, viral infections, immune deficiencies, local environmental factors like scars or implants as well as chronic inflammatory conditions. In contrast to many epithelial tumors, a clear multistage tumorigenesis or a clear precursor-sarcoma-sequence so far has rarely been identified in soft tissue tumors. However, the demonstration of common genetic alterations in the case of benign and malignant lipomatous tumors [2, 22] as well as benign and malignant nerve sheath tumors [3, 4] makes it reasonable that a stepwise development in soft tissues tumors is relevant for at least some entities.
In a previous study, an experimental animal model has been presented in which a high incidence of malignant soft tissue tumors arose around implanted biomaterials [5] . Sarcoma induction by biomaterials required direct contact with the respective substances. Remarkably, a broad spectrum of soft tissue tumors developed, obviously independent of the specific kind of agent implanted and lacking any consistent correlation between biomaterial groups and specific histological type of tumor. This observation suggested that it is not a specific genetic damage, interfering with a defined pathway, which is induced. In this case, one would expect a less heterogenous spectrum of histologic entities, as are described for several specific carcinogenic substances resulting in defined tumor entities, e.g. mesotheliomas following asbestos exposure [23] . The heterogenous spectrum of lesions observed in this study rather argues for a (or several) more or less random insult(s). What might be the nature of this insult?
A characteristic hallmark of tumors developing in this model was the reaction of the peri-tumorous tissue, characterized by a chronic inflammation and hyperproliferative changes at peri-implantational sites, known as a typical response to foreign materials for a long time [6] . Chronic inflammation, characterized by free radical stress, can be a significant contributor to carcinogenesis [13, 24] . One could easily imagine that the microenvironment around the implants, probably through inflammationmediated factors, might interfere with replication repair enzymes in this proliferation. Such a defect is expected to be reflected by microsatellite instability. There are several observations providing evidence that chronic inflammation indeed can result in an impaired mismatch-repair capacity, even in the absence of any genetic inactivation of the mismatch repair system [11] [12] [13] . Although rare, microsatellite instability has been observed in sarcomas of different histogenetic type [14, 16] . This prompted us to search for microsatellite instability in biomaterial-induced sarcomas. However, in the present study we have not observed a single microsatellite instability, neither in fully developed tumors nor in preneoplastic lesions. Based on this observation, we found no evidence that a replicationrepair-associated defect is crucial for biomaterial-induced sarcomagenesis.
If this is not the case, what could be the responsible factor? As stated above, with respect to the heterogenous spectrum of tumor entities, it seems unlikely that a specific genetic insult underlies biomaterial-induced sarcomagenesis. Although the diversity of different physical compounds able to induce soft tissue tumors argues against a direct toxic effect of substances released, there is obviously the possibility of a genotoxic effect with subsequent genetic or epigenetic changes. Alternatively, sarcomagenesis is probably associated with genetic instabilty on the chromosomal (cytogenetic) level, for example induced by interference with cell check points. Carcinogen-induced sarcomagenesis in Trp53+/− mice suggests that loss of p53 function is, at least in part, an important mechanism in the development of sarcomas at the implantation site [24, 25] . Since the hypothesis that a mutator phenotype could be responsible for the development of biomaterial-induced sarcomas is not supported by our data, further investigation should test the latter possibilities.
